相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Huntington's disease: from pathology and genetics to potential therapies
Sara Imarisio et al.
BIOCHEMICAL JOURNAL (2008)
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Kavitha S. Rao et al.
BIOMATERIALS (2008)
Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations
Tushar K. Vyas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
Edward L. Tobinick et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Mixed results for disease-modification strategies for Alzheimer's disease
Alisa Opar
NATURE REVIEWS DRUG DISCOVERY (2008)
Symptomatic treatment of Huntington disease
Octavian R. Adam et al.
NEUROTHERAPEUTICS (2008)
Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models
Scott B. Raymond et al.
PLOS ONE (2008)
Emulsion-based delivery systems for lipophilioc bioactive components
D. J. McClements et al.
JOURNAL OF FOOD SCIENCE (2007)
Role of nanotechnology in pharmaceutical product development
Harikrishna Devalapally et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Targeting the central nervous system:: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123
G. Tosi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer
Rong-Qin Huang et al.
FASEB JOURNAL (2007)
Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS
Leah R. Hanson et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys
David N. Hovland et al.
TOXICOLOGIC PATHOLOGY (2007)
Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier
Yung-Chih Kuo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S. Schneider et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Molecular Trojan horses for blood-brain barrier drug delivery
William M. Pardridge
CURRENT OPINION IN PHARMACOLOGY (2006)
Gene delivery to the spinal cord: Comparison between lentiviral, adenoviral, and retroviral vector delivery systems
Ahmed A. Abdellatif et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse
Y Machida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
RNA knockdown as a potential therapeutic strategy in Parkinson's disease
FP Manfredsson et al.
GENE THERAPY (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats
A Ambruosi et al.
JOURNAL OF DRUG TARGETING (2006)
Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan
TK Vyas et al.
AAPS PHARMSCITECH (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier
L Costantino et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory
RL Buckner et al.
JOURNAL OF NEUROSCIENCE (2005)
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease
M Sun et al.
BRAIN RESEARCH (2005)
Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury
MTG da Cruz et al.
GENE THERAPY (2005)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Nasal drug administration: Potential for targeted central nervous system delivery
CL Graff et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
MH Tuszynski et al.
NATURE MEDICINE (2005)
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model
GP Lim et al.
JOURNAL OF NEUROSCIENCE (2005)
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice
R De Rosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector
M Azzouz et al.
NEUROREPORT (2004)
The potential of nasal application for delivery to the central brain - a microdialysis study of fluorescein in rats
MA Bagger et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Paclitaxel nanoparticles for the potential treatment of brain tumors
JM Koziara et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
WQ Sun et al.
BIOMATERIALS (2004)
Is nose-to-brain transport of drugs in man a reality?
L Illum
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
RG Thorne et al.
NEUROSCIENCE (2004)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor:: Results of a phase I study
J Bloch et al.
HUMAN GENE THERAPY (2004)
Brain uptake of thiamine-coated nanoparticles
PR Lockman et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Alzheimer disease in the US population - Prevalence estimates using the 2000 census
LE Hebert et al.
ARCHIVES OF NEUROLOGY (2003)
The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins
K Bogman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Drug and gene delivery to the brain: The vascular route
WM Pardridge
NEURON (2002)
Antisense gene therapy of brain cancer with an artificial virus gene delivery system
Y Zhang et al.
MOLECULAR THERAPY (2002)
Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH
JX Wu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Biomedicine - Toxic proteins in neurodegenerative disease
JP Taylor et al.
SCIENCE (2002)
Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent:: Pharmacokinetics and distribution of doxorubicin in brain and other tissues
GP Zara et al.
JOURNAL OF DRUG TARGETING (2002)
Functional expression and localization of P-glycoprotein at the blood brain barrier
R Bendayan et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
Growth-factor gene therapy for neurodegenerative disorders
MH Tuszynski
LANCET NEUROLOGY (2002)
Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy
PB Storm et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Drug and gene targeting to the brain with molecular Trojan horses
WM Pardridge
NATURE REVIEWS DRUG DISCOVERY (2002)
Recombinant proteins for neurodegenerative diseases: the delivery issue
P Aebischer et al.
TRENDS IN NEUROSCIENCES (2001)
Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion
XF Liu et al.
NEUROSCIENCE LETTERS (2001)
Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage
XF Liu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
Delivery of neurotrophic factors to the central nervous system - Pharmacokinetic considerations
RG Thorne et al.
CLINICAL PHARMACOKINETICS (2001)
Prodrugs in nasal drug delivery
GS Tirucherai et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier
T Kageyama et al.
BRAIN RESEARCH (2000)
Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France
PM Preux et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
HL Fehm et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art
RH Müller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
The blood-brain barrier and bilirubin encephalopathy
RP Wennberg
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
Increased drug delivery to the brain by P-glycoprotein inhibition
AJM Sadeque et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Gene therapy in the CNS
LC Costantini et al.
GENE THERAPY (2000)
分享论文
